Volume 10, Issue 2 (4-2006)                   IBJ 2006, 10(2): 105-109 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kariminia A, K. Ardestani S, Al-Sadat Ardestani N, Sepehry H, Darabi H. Interferon Gamma Unresponsiveness Due to Down-Regulation of IFN-γR Expression in Experimental Cutaneous Leishmaniasis. IBJ 2006; 10 (2) :105-109
URL: http://ibj.pasteur.ac.ir/article-1-356-en.html
Abstract:  
It is now well documented that interferon gamma (IFN-γ) is the indispensable cytokine for inducing protective immunity against experimental and human cutaneous leishmaniaisis. The importance of IFN-γ receptor (IFN-γR) has also been studied. In the present study, we made attempts to find out whether L. major infection is able to alter the expression of IFN-γR in vivo. In addition, we studied the responsiveness to IFN-γ ex vivo. To do that, we assessed the expression of CD119 (IFN-γRα ) on CD45+ cells isolated from draining lymph nodes of infected and uninfected BALB/c and C57BL/6 mice by flow cytometry. The MFI (mean fluorescence intensities) of CD119 on uninfected BALB/c mice were 192.8 ± 18.4 but the CD119 MFI of infected BALB/c mice were remarkably decreased (107.9±40.8). CD119 MFI of uninfected and infected C57BL/6 mice were 276.2 ± 17.1 and 140.4±43.0 respectively Moreover, we measured the production of nitric oxide (NO) by these cells in the presence of IFN-γ in order to study the function of IFN-γR. NO production by draining lymph nodes cells of infected C57BL/6 mice in response to recombinant murine IFN-γ was significantly higher than the cells of infected BALB/c mice (37.5 ± 0.6 and 11.6 ± 0.5 µM respectively, p<0.05). Therefore, our results confirm the in vitro reports regarding the impairment of IFN-γ responsiveness due to Leishmania infection.
Type of Study: Full Length/Original Article |

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Biomedical Journal

Designed & Developed by : Yektaweb